Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Alitretinoin may help treat alopecia areata.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Polycaprolactone gel is effective and safe for treating nasolabial folds.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Anti-TNF therapy can cause hair loss and skin issues.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Oral contraceptives with cyproterone acetate improved quality of life for women with PCOS more than those with levonorgestrel.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Oral baricitinib is effective and safe for treating alopecia areata.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Acyzol could help treat conditions caused by zinc deficiency.